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Abstract Large amounts of rich, heterogeneous information nowadays rou-
tinely collected by health care providers across the world possess remarkable
potential for the extraction of novel medical data and the assessment of differ-
ent practices in real-world conditions. Specifically in this work our goal is to
use Electronic Health Records (EHRs) to predict progression patterns of future
diagnoses of ailments for a particular patient, given the patient’s present diag-
nostic history. Following the highly promising results of a recently proposed
approach which introduced the diagnosis history vector representation of a pa-
tient’s diagnostic record, we introduce a series of improvements to the model
and conduct thorough experiments that demonstrate its scalability, accuracy, and
practicability in the clinical context. We show that the model is able to capture
well the interaction between a large number of ailments which correspond to
the most frequent diagnoses, show how the original learning framework can be
adapted to increase its prediction specificity, and describe a principled, prob-
abilistic method for incorporating explicit, human clinical knowledge to over-
come semantic limitations of the raw EHR data.
Keywords Electronic medical records · EMRs · Bayesian · risk · disease ·
epidemiology
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1 Introduction
The trend of increased efforts in health data collection and its ready digitiza-
tion is widely recognized as a major change in the manner medical data is used.
In particular the collection of Electronic Health Records (EHRs) has recently
started attracting major translational research efforts in the domains of data min-
ing, knowledge extraction, and machine learning (Xu et al., 2016; Christensen
and Ellingsen, 2016). Electronic Health Records have already been extensively
used in large scale sociodemographic surveys of death causes (RGI-CGHR Col-
laborators, 2009), clinical epidemiological (Paul et al., 2015c; Bhatnagar et al.,
2015; Crawford et al., 2010) and pharmacoepidemiological studies (Wettermark
et al., 2013; Lau et al., 2011; Paul et al., 2015b), as well as in the analysis
of pharmacovigilance (Nadkarni, 2010; Liu et al., 2013; Coloma et al., 2013),
health related economic effects (Canavan et al., 2015; Bessou et al., 2015), and
public health (Birkhead et al., 2015; Paul et al., 2015a; Kukafka et al., 2007;
Menachemi and Collum, 2011). Considering that this research is still in its early
stages it is undeniably wise to refrain from overly ambitious predictions regard-
ing the type of knowledge which may be discovered in this manner, at the very
least it is true that few domains of application of the aforesaid techniques hold
as much promise for impact. It is sufficient to observe the potential benefits that
an increased understanding of complex interactions of lifestyle diseases in the
economically developed world could deliver in terms of personalized medicine
or health care policy (Fan et al., 2016) on the one hand, and a wiser utilization of
resources, aid, and educational material in the economically deprived countries
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(RGI-CGHR Collaborators, 2009), to appreciate the global and overarching po-
tential.
Public health care is an issue of major global significance and concern. On
one end of the spectrum, the developing world is still plagued by “diseases of
poverty” which are nearly non-existent in the most technologically developed
countries; on the other end, the health risk profile of industrially leading na-
tions has dramatically changed in recent history with an increased skew towards
so-called “diseases of affluence”, as illustrated in Figure 1 (data taken from
(Murray et al., 2001)).
Hence, health care management poses challenges both in the sphere of pol-
icy making and scientific research. Considering the complexity of problems at
hand, it is unsurprising that there is an ever-increasing effort invested in a di-
verse range of promising avenues. Yet, the available resources are inherently
limited. To ensure their best usage it is crucial both to develop an understanding
of the related epidemiology, as well as to be able to communicate this knowl-
edge effectively to those who can benefit from it: governments (Berwick and
Hackbarth, 2012), the medical research community (Beykikhoshk et al., 2015a,
2016; Andrei and Arandjelovic´, 2016), health care practitioners (Arandjelovic´,
2015a; Osuala and Arandjelovic´, 2017), and patients (Beykikhoshk et al., 2014;
Barracliffe et al., 2017).
The associations between diseases and a wide variety of risk factors are un-
derlain by a complex web of interactions. This is particularly the case for the
diseases of the developed world. The key premise of the present work is that to
facilitate the understanding of this complexity and the discovery of meaningful
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patterns within it, it is crucial to make use of the vast amounts of data routinely
collected by health services in industrially and technologically developed coun-
tries.
Our specific aim is to develop a framework which allows a health practitioner
(e.g. a doctor or a clinician) to manipulate the available patient information in an
intuitive yet powerful fashion. Such a framework would, on one end of the util-
ity spectrum, facilitate a deepening of disease understanding, and on the other,
provide the practitioner with a tool which can be used to incentivize the patient
at risk to make the required lifestyle changes.
1.1 Data: electronic medical records
This work leverages the large amounts of medical data routinely collected and
stored in electronic form by health providers in most developed countries. This
is a rich data source which contains a variety of information about each pa-
tient including the patient’s age and sex, mother tongue, religion, marital status,
profession, etc. In the context of the present work, of main interest is the in-
formation collected each time a patient is admitted to the hospital (including
out-patient visits to general practitioners or specialists). The format of this data
is explained next.
Each time a patient is admitted to the hospital the reason for the admission, as
determined by the medical practitioner in primary charge during the admission,
is recorded in the patient’s medical history. This is performed using a standard-
ized coding schema such as that provided by the International Statistical Classi-
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fication of Diseases and Related Health Problems (ICD-10) (World Health Or-
ganization, 2004) and the related Australian Refined Diagnosis-Related Groups
(AR-DRGs).
These have hierarchical structures (Arandjelovic´, 2016). ICD-10, for exam-
ple, contains 22 chapters, each chapter encompassing a spectrum of related
health issues (usually symptomatically rather than etiologically related). For ex-
ample, ICD-10 Chapter 4 which includes codes E00-E90, covers “Endocrine,
nutritional and metabolic diseases”. At each subsequent depth level of the tree
the grouping is refined and the scope of conditions narrowed down. In this paper
we use the classification attained at the depth of two of ICD-10, which achieves
a good compromise between specificity and frequency of occurrence. This re-
sults in each diagnosis being given a three character code which comprises a
leading capital letter (A-Z, first grouping level), followed by a two digit number
(further refinement). For example, E66 codes for “Obesity” within the broader
range of “Endocrine, nutritional and metabolic diseases”.
2 Modelling comorbidity progression
The major contribution of this work is a novel disease progression model. The
principal challenge is posed by the need for a model which is sufficiently flexible
to be able to capture complex patterns of comorbidity development, while at
the same time constrained enough to facilitate learning from a real-world data
corpus.
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2.1 Bottom-up modelling
The problem of modelling disease progression has already attracted a consid-
erable amount of research attention. Most previous research focuses on spe-
cific individual diseases, such as type-II diabetes mellitus (Topp et al., 2000;
De Gaetano et al., 2008) or heart disease (Ye et al., 2012). These methods are
inherently ‘low-level’ based in the sense that they explicitly model known phys-
iological changes that affect disease progression. For example, the modelling
of the progression of type-II diabetes may include low-level models of β-cell
mass changes, and insulin and glucose dynamics (Topp et al., 2000), with the
free parameters (e.g. β-cell replication rate) of the models adopted from previ-
ous empirical studies. Higher level disease progression then emerges from the
interaction of low-level models.
The low-level approach to disease modelling has several limitations. Firstly,
by their very nature these models are limited to specific diseases only and cannot
be readily adapted to deal with conditions with entirely different etiologies. Sec-
ondly, the modelling is practically constrained usually to a single condition, two
at the most, as the complexity of modelled system increases dramatically with
the inclusion of a greater number of conditions. This observation is of major
significance as most diseases of the developed world are most often accompa-
nied and affected by multiple comorbidities. Lastly, the range of diseases which
can be modelled in this manner is limited to diseases which are sufficiently well
understood and studied to allow for the free model parameters to be set reliably;
even for type-II diabetes, which has been studied extensively, at present some
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parameters must be set in an ad hoc manner and others using in vitro rather than
in vivo data (Topp et al., 2000).
2.2 Direct high-level modelling
Given the significance of the disadvantages of low-level based disease progres-
sion models, in this paper an alternative approach is pursued, that of seeking
to describe disease progression as well as the interplay of different comorbidi-
ties directly on the ‘high-level’ as observed by a medical practitioner. Previous
research in this area is far scarcer than that on low-level modelling; a possible
reason for this is probably to be found in the until recently limited availability
of large-scale medical records data. The central idea of the existing corpus of
work is to regard disease progression as a discrete sequence of events, with the
progression governed by what is assumed to be a first-order Markov process
(Sukkar et al., 2012; Jackson et al., 2003).
A high-level view of disease progression is seen as being reflected by a pa-
tient’s diagnostic history H = d1 → d2 → . . . → dn where di is a discrete
variable whose value is a code corresponding to the i-th of n diagnoses on the
patient’s record. The parameters of the underlying first-order Markov model are
then learnt by estimating transition probabilities p(d′ → d′′) for all transitions
encountered in training (the remaining transition probabilities are usually set to
some low value rather than 0, using a pseudocount based estimate) (Wang et al.,
2014; Folino and Pizzuti, 2011; Bartolomeo et al., 2008). The model can be ap-
plied to predict the diagnosis dn+1 expected to follow from the current history
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by model likelihood maximization:
dn+1 = argmax
d
p(dn → d). (1)
Alternatively, it may be used to estimate the probability of a particular diagnosis
d∗ at some point in future:
pf (d
∗) =
∑
d
[p(d→ d∗) pf (d)], (2)
or to sample the space of possible histories:
H ′ = d1 → d2 → . . .→ dn 99K dn+1 99K dn+2 . . . . (3)
The primary purpose of the Markovian assumption is to constrain the mech-
anism underlying a specific process and thus formulate it in a manner which
leads to a tractable learning problem. Although it is seldom strictly true, that
it is often a reasonable approximation to make is witnessed by its successful
application across a diverse range of disciplines; examples of modelled phe-
nomena include meteorological events (Gabriel and Neumann, 1962), software
usage patterns (Whittaker and Thomason, 1994), breast cancer screening (Duffy
and Yau, 1995), human motion and behaviour (Lee et al., 2005; Arandjelovic´,
2011), and many others. Nonetheless, the key premise motivating the model in
this paper is that the Markovian assumption is in fact not appropriate for the
high-level modelling of disease progression (note that this does not reject its
possible applicability in disease progression modelling on different levels of
abstraction). Indeed, we will demonstrate this empirically. The aforementioned
premise is readily substantiated using a theoretical argument as well. Consider a
patient who is admitted for what is diagnosed as a serious chronic illness. If the
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same patient is subsequently admitted for an unrelated ailment, possibly a triv-
ial one, the knowledge of the serious underlying problem is lost and the power
to predict the next related diagnosis lost. The model proposed in the section
which follows solves this problem, while at the same retaining the tractability
of Markov process based approaches.
2.3 Proposed approach
In this paper our aim is to predict the probability of a specific diagnosis a fol-
lowing the patient history H:
p(H → a|H). (4)
The difficulty of formulating this as a tractable learning problem lies in the
fact that the space of possible histories is infinite as H can be of an arbitrary
length. Even if the length l(H) is limited, the number of possible histories is
extremely large: [l(H)]na where na is the number of different diagnosis codes.
Therefore it is necessary to make an approximation which constrains and sim-
plifies the task. We already argued why the Markovian assumption on the level
of diagnosis codes is inappropriate. In its stead we propose a different rep-
resentation of a patient’s state, particularly suitable for the modelling of dis-
ease progression (Arandjelovic´, 2015b). Consider a particular diagnosis history
H = d1 → . . . → dn. The proposed method makes use of the well known ob-
servation that when it comes to chronic diseases, the very presence of past com-
plications strongly predicts future complications (Mudge et al., 2011; Friedman
et al., 2008–2009; Dharmarajan et al., 2013; Butler and Kalogeropoulos, 2012).
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Thus, a history H is represented using a history vector v = v(H) which is a
fixed length vector with binary values (Beykikhoshk et al., 2015b). Each vector
element corresponds to a specific diagnosis code (except for one special element
explained shortly) and its value is 1 if and only if the corresponding diagnosis
is present in the history:
∀d ∈ D. v(H)i(d) =

1 : ∃j. H = H1 → dj → H2 ∧ d = dj
0 : otherwise
where D is the set of diagnosis codes, i(d) indexes the diagnosis code d in a
history vector, and H1,2 may take on degenerate forms of empty histories. By
collapsing an arbitrary length history of diagnoses onto a fixed length vector,
the space of possible states over which learning is performed is dramatically
reduced and the problem immediately made far more tractable. Notice the im-
portance of the observation that it is the presence of past complications which
most strongly predicts future ailments, given that under this representation any
information on the ordering of diagnoses is discarded. The binary nature of the
representation also has the effect of reducing the size of the space over which in-
ference is performed. In this case, this is achieved by discarding information on
the number of repeated diagnoses and in this manner it too predicates the over-
whelming predictive power of the presence of history of a particular ailment,
rather than the number of the corresponding diagnoses.
The disease progression modelling problem at hand is thus reduced to the
task of learning transition probabilities between different patient history vectors:
p(v(H)→ v(H ′)). (5)
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It is important to observe that unlike in the case of Markov process models
working on the diagnosis level when the number of possible transition proba-
bilities is close to na2, here the transition space is far sparser. Specifically, note
that it is impossible to observe a transition from a history vector which codes
for the existence of a particular past diagnosis to one which does not, that is:
v(H)i(d) = 1 ∧ v(H ′)i(d) = 0⇒ p(v(H)→ v(H ′)) = 0. (6)
The converse does not hold however. Moreover, possible transitions can be only
those which include either no changes to the history vector (repeated diagnosis)
or which encode exactly one additional diagnosis:
p(v(H)→ v(H ′))
> 0 : ∀a. v(H)i(d) = 1⇒ v(H ′)i(d) = 1
and∣∣{a : v(H)i(d) = 1}∣∣ ≤ 1 + ∣∣{a : v(H ′)i(d) = 1}∣∣
= 0 : otherwise
(7)
This gives the upper bound for the number of non-zero probability transitions
of na × 2na . In practice the actual number of transitions is far smaller (several
orders of magnitude for the data set described in the next section) which allows
the learnt model to be stored and accessed efficiently.
The final aspect of the proposed model concerns transitions with probabili-
ties which do not vanish but which are nonetheless very low. These transitions
can be reasonably considered to be noise in the sense that the corresponding
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probability estimates are unreliable due to low sample size. Hence diagnosis
history vectors are constructed using only the nˆd most common diagnoses and
merge the remaining nd − nˆd types into a single special code ‘other’. Thus, the
dimensionality of diagnosis history vectors becomes nˆd + 1. The soundness of
this approach can be readily observed by examining the plot in Figure 2 which
shows that only a small number of diagnosis types covers a vast number of all
data. For example the top 30 most frequent types account for 75% of all diag-
noses.
A conceptual illustration of the method is shown in Figure 3.
2.4 Limitations and questions
One of our contributions of the present work is in the form of an analysis which
scrutinizes the expectation that the method would scale well. In the original
work (Arandjelovic´, 2015b) it was argued that the predictive performance of
the method, reported with explicit modelling of the 30 most frequent diagnosis
types only, could be maintained as a greater number of diagnosis types is in-
cluded in the model as most practical applications would demand. The original
paper did not investigate this; rather, the number of salient, explicitly modelled
diagnoses was set in an ad hoc manner to 30, explaining approximately 75% of
the data corpus (Arandjelovic´, 2015b). If our expectation of performance dete-
rioration with an increased number of explicitly modelled diagnoses is correct,
and if the rate of deterioration is high, the model could end up being of lit-
tle practical significance: on the one end of the parameter spectrum the model
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would provide high accuracy but insufficient specificity for its predictions to
be practically useful, and on the other high specificity but poor accuracy for
its predictions to be relied upon. Thus an analysis of this aspect of the original
method is necessary before any practical use can be considered; our experiments
as regards this issue are presented in Section 4.3.
3 Further technical contributions
In this section we introduce our two main technical contributions. Our third
contribution in the form of novel analyses and empirical results which highlight
important and promising future research directions is presented in Section 4.
3.1 Improving the specificity of the model
The first major contribution of the present work goes to the very heart of the
learning framework underlying the diagnostic progression model, and concerns
the issue of the space over which learning is performed. In other words we
propose a paradigm change in terms of what is explicitly learnt.
Recall from the previous section that the method described by (Arandjelovic´,
2015b) learns the probabilities of transitions from the space of history vectors
to the same space of history vectors i.e. it learns p(H ′|H) where H is a patient
history vector and H a possible extension to that history, H ′ = H → d. This
approach naturally follows from the structure of the problem: both H and H ′
are states in a Markov chain and indeed the baseline formulation of this class
of problems learns amongst other things precisely these transition probabilities.
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However, the very aspect of the history vector representation which makes it a
powerful feature for longitudinal pattern extraction, in this instance introduces a
significant practical limitation. Because history vectors are binarized, in general
a specific transition does not uniquely determine the diagnosis which caused the
transition to occur. In particular this occurs when a diagnosis already recorded in
a patient’s history is repeated – the transition fromH to itself does not allow the
method to distinguish between different diagnoses in the patient’s history and
determine which effected the transition (Vasiljeva and Arandjelovic´, 2016b).
This is a major limitation given that many of the most serious diseases tend to
be chronic in nature.
The method introduced in the present paper solves the described problem by
changing the space over which learning is performed. In particular, rather than
learning the probabilities of transitions between history vectors themselves, we
learn the probabilities of follow up diagnoses directly. It can be readily seen that
this is a stronger learning task in the sense that knowing the follow-up diagnosis
d allows for the computation of the next Markov chain state H ′ = H → d
without ambiguity whereas the opposite is not the case, as described previously.
What makes this learning choice particularly sensible is that it does not carry the
burden of either greater computational complexity nor learning challenge – the
dimensionality of the space over which learning is performed stays exactly the
same (it is governed by the choice of the number of salient diagnoses), which
remains as densely populated as before. Hence this learning paradigm change is
unambiguously superior to that described originally.
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3.2 Risk driven inference
Our second key technical novelty concerns a major challenge in the develop-
ment of models underlain by data from EHRs, which emerges from the perva-
sive problem known as the semantic gap (Vasiljeva and Arandjelovic´, 2016c).
In colloquial terms, the problem is readily understood as arising from the lack
of understanding of, say, disease aetiology and physiology that an automatic
method has in the interpretation of data from EHRs. For example, a human ex-
pert (such as a general practitioner or a specialist) who does have such knowl-
edge, may be readily able to discount even the consideration of certain dis-
ease interactions which may be difficult to infer using a purely data driven ap-
proach that machine methods generally employ. To overcome this challenge
some means of interaction, that is, information provision between an expert and
a computer algorithm is needed. Yet this interaction has to be intuitive, and re-
quire little effort and computing expertize.
The original authors correctly point out and thereafter empirically demon-
strate that a major limitation in the use of Markovian models lies in their ‘for-
getfulness’. This feature seemingly makes them inappropriate for the modelling
under consideration here. They overcome this limitation by incorporating mem-
ory into the state representation itself. In particular they describe what they term
a history vector which is a representation of a patient’s diagnostic history in the
form of a binary vector which encodes the types of diagnoses that the patient
has been given in the past.
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3.2.1 Identifying confounding factors
Consider two history vectors, Hx and Hy, which differ in the presence of only
a single past diagnosis dd. In other words, all bits in Hx and Hy are the same
except for exactly one. A specific follow-up diagnosis df , causes the transition
of Hx and Hy to respectively H ′x and H ′y. We show how it can be automatically
inferred if the differential diagnosis between hx and hy is one which affects
the probability of df . We achieve this using a Bayesian approach which read-
ily lends itself to asymmetrical risk driven inference, as described next. If the
probability of df is not affected by the presence of dd (in the context of other
historical diagnoses in Hx and Hy, of course) then the transition data from the
database of EHRs can be merged and thus used to estimate the aforesaid proba-
bility with higher precision so clearly this is a highly desirable goal which can
be used to reduce the amount of confounding factors greatly and improve the
accuracy of the learnt models.
Consider what happens if Hx and Hy are indeed merged in the context of
the prediction of df . In such a case, the number of the observed transitions from
Hx to Hx → df and from Hy to Hy → df are considered as equivalent. By
considering them jointly a new probability of df from either Hx or Hy can be
estimated. Call this probability z. The total risk ρ of the aforesaid merge can
then be computed as a sum of risks associated with the actual probabilities of
df following Hx and Hy respectively:
ρ = ρx + ρy. (8)
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This risk emerges as a consequence of the fact that the empirical nature of EHRs
inherently involves a degree of stochasticity which means that there can never
be absolute certainty that dd is indeed entirely inconsequential in the context
of this prediction. Instead, employing Bayesian framework, it is necessary to
integrate over the latent probability of df following Hx and Hy and weight this
with the associated relative risk. In this manner for ρx the risk can be written as:
ρx = Cx
∫ 1
z
|x− z|p(x|nx)dx+ (9)
+ (1− Cx)
∫ z
0
|z − x|p(x|nx)dx. (10)
What this expression captures can be readily understood as follows. The first
term quantifies the risk of z underestimating the true probability x of df follow-
ingHx (hence the integration is for x > z). Similarly the second term quantifies
the risk of z overestimating the true probability x of df followingHx (hence the
integration is for x < z). The two risks are in general weighted asymmetrically,
as governed by the constant Cx ∈ [0, 1] which should be set by a relevant medi-
cal professional. The aforesaid asymmetry captures what are in general different
‘costs’ of overestimating and underestimating the probability of a particular di-
agnosis. For example, the cost of underestimating the probability of a terminal
diagnosis is much greater than of overestimating it by the same amount. In this
case Cx should be large i.e. closer to 1.
Continuing from (9), using Bayes theorem the term p(x|nx) can be rewritten
as follows:
p(x|nx) = p(nx|x)p(x)
p(nx)
, (11)
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where nx is the number of cases in which df was the next diagnosis follow-
ing Hx, of the total of Nx transitions present in the EHRs database. Since the
method has no means of establishing an informative prior on the transition prob-
ability x, an uninformative prior p(x) is used which leads to p(x) = 1 since
x ∈ [0, 1]. Moreover, p(nx|x) is readily identifiable as a binomial distribution
with the parameter x and the number of draws Nx allowing p(x|nx) to be ex-
panded further as follows:
p(x|nx) = p(nx|x)
p(nx)
(12)
=
(
Nx
nx
)
xnx(1− x)Nx−nx∫ 1
0 p(nx|w)dw
(13)
=
xnx(1− x)Nx−nx∫ 1
0
(
Nx
nx
)
wnx(1− w)Nx−nxdw
(14)
=
xnx(1− x)Nx−nx(
Nx
nx
)
β(nx + 1, Nx − nx + 1)
(15)
where β(.) is the Euler beta function, and simple marginalization over x is per-
formed in the denominator. This expression can be substituted back into (9) and
(10), and then (8), and the integration performed numerically (which is both
simple and fast, given that it is a simple integration in 1D).
Notes and remarks on practical application It is insightful to highlight sev-
eral important practical aspects of the proposed technique. Firstly, once im-
plemented as software it is intuitive to use – the tradeoff between over- and
under-diagnosis is a concept routinely dealt with by medical professionals, and
it is simply set using a single constant which balances the two risks. The risk
is also readily interpretable. For example, for a terminal diagnosis the integrand
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in (9) can be interpreted as computing the number of individuals who would
be incorrectly expected to have a terminal diagnosis – an undesirable mistake
considering the potential emotional stress, to begin with. Similarly, for a ter-
minal diagnosis the integrand in (10) estimates the number of individuals who
would experience a terminal episode which would not be predicted – arguably
an even more serious mistake in that it ipso facto involves the loss of life. The
acceptable tradeoff can be made by a clinician either on the level of an indi-
vidual patient, for a specific diagnosis, or for an entire class of diagnoses (e.g.
the same baseline risk tradeoff could be set for an entire ICD chapter, such as
chapter IX which covers circulatory system diseases). In summary, the proposed
technique is simple and intuitive to use, and it allows a high degree of flexibility
in the choice of specificity or generality in application.
4 Evaluation
In this section we summarize some of the experiments we conducted to evaluate
the proposed framework, and derive useful insights which illuminate possible
avenues for improvement and future work.
4.1 EHR data
In an effort to reduce the possibility of introducing variability due to confound-
ing variables, we sought to standardize our evaluation protocol as much as possi-
ble with that adopted by previous work. Hence we requested access to the large
collection of EHRs described by (Arandjelovic´, 2015b) and were kindly pro-
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vided 75% of the records used in the aforementioned paper. For completeness
here we summarize the key features of this subset.
The EHRs adopted for evaluation were collected by a large private hospital
in Fife, Scotland. The distribution of patient age in the database is 75±14 years,
the youngest and oldest patients being 18 months and 105 years old respectively,
with the male to female ratio 56 : 44. Approximately 23% of the patients in the
database have a date of death associated with their EHR, which means that they
are deceased and thus have a record of a terminal diagnosis. The entire EHR
collection spans a period of 10 years, with the average number of diagnoses per
patient of 9.9± 64.0.
4.2 Baseline model validation
Interestingly, on our data set the patient’s age was found not to be associ-
ated with the number of admissions on record, while a low positive correlation
(r = 0.14) was found between the patient’s age and the number of conditions
the patient had been diagnosed with at some point in the past – see Figures 4(b)
and 4(b). A better predictor of the number of admissions was found to be the
presence of a particular diagnosis (e.g. a high number of admissions is associ-
ated with the presence of the diagnoses of mental disorders, renal and cardio-
vascular conditions), as illustrated in Figures 5(a) and 5(b). Further insight can
be gained by examining Figures 6(a) and 6(b) which summarize the repeated
diagnosis statistics across different conditions. A mental disorder diagnosis or
dialysis treatment for example predict both a high probability of a repeated di-
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agnosis, as well as a high total number of the diagnosis type on record. These
results are consistent with previous studies in the literature (Vigod et al., 2013;
Kilkenny et al., 2013; Allaudeen et al., 2011) and support our diagnosis pres-
ence based model.
4.2.1 Next diagnosis prediction
To evaluate the predictive power of the proposed model, we examined its perfor-
mance in the prediction of the next diagnosis based on a patient’s prior diagnosis
history, and compared this with the performance of the Markov process based
approach described previously; see (1)–(3). Both methods were trained using
an 80-20 split of data into training and test. Specifically, 80% of the data corpus
was used to learn the model parameters – conditional probabilities p(Hˆ → d|Hˆ)
in the case of the proposed model and p(d→ d′) for the Markov process based
model. The remaining 20% of the data was used as test input. For each test
patient we considered the predictions obtained by the two methods given all
possible partial histories. In other words, given a patient with the full diagnosis
history H = d1 → d2 → . . .→ dn we obtain predictions using partial histories
Hk = d1 → . . .→ dk for k = 1 . . . n− 1.
A summary of the results is given in Figure 7 which shows the cumulative
match characteristic curves corresponding to the two methods – each point on a
curve represents the proportion of cases (ordinate) for which the actual correct
diagnosis type is at worst predicted with a specific rank (abscissa). The first
thing that is readily observed from the plot is that the proposed method (blue
line) vastly outperforms the Markov process based approach (red line). What is
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more, the accuracy of our method is rather remarkable – it correctly predicts the
type of the next diagnosis for a patient in 82% of the cases (rank-1). Already
at rank-2 the accuracy is nearly 90%. In comparison, the Markov process based
method achieves only 35% accuracy at rank-1, less than 50% at rank-2, and
reaches 90% only at rank-17.
It is interesting to observe a particular feature of the CMC plot for the pro-
posed method. Notice its tail behaviour – at rank-25 and above, the Markov
process based approach catches up and actually performs better. While perfor-
mance at such a high rank is not of direct practical interest, it is insightful to
consider how this observation can be explained given that it is highly unlikely
for it to be a mere statistical anomaly, considering the amount of data used to
estimate the characteristics. The answer is readily revealed by considering the
plot in Figure 8 which shows the dependency between the average rank of the
proposed method’s prediction and the length of the partial history used as input.
Specifically, notice that higher ranks (i.e. worse performance) are associated
with short histories. Put differently, when there is little information in a patient’s
history, there is more uncertainty about the patient’s possible future ailments.
This observation too strongly supports the validity of our model as it shows that
accumulating evidence is used and represented in a more meaningful and robust
way which allows for the learning of complex interactions between conditions
and their development. Finally, this is illustrated in Figure 7 which also shows
the plot of the proposed method’s CMC curve restricted to test histories con-
taining at least 5 prior diagnoses. In this case, rank-1 and rank-2 performances
reach the remarkable accuracy of 91% and 97% respectively.
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4.2.2 Long-term prediction
Given the outstanding performance of our method in predicting the type of
the next diagnosis given the patient’s current medical history, we next con-
sidered how the proposed model performs in long-term predictions. Consid-
ering that we are now dealing with sequences of future diagnoses and thus a
much greater space of possible options, the characterization of performance us-
ing CMC curves is impractical. Rather, we now compare our approach with
the Markov process based method by comparing the corresponding conditional
probabilities for the actual progression observed in the data. In other words, for
the prediction following a partial history Hˆ of the length k and the correct full
history H = Hˆ → dk+1 → . . . → dn we compute the log-ratio of conditional
probabilities:
ρ = log
(
pMarkov(Hˆ → dk+1 → . . .→ dn|Hˆ)
pproposed(Hˆ → dk+1 → . . .→ dn|Hˆ)
)
(16)
A positive value of ρ means that the Markov process based method performed
better and a negative value that the proposed method did. The greater the ab-
solute value of ρ the greater is the measured difference in performance in the
corresponding direction. As before we divide the data into training and test sets
using an 80-20 split and consider the predictions for all possible partial histories
in the test set.
A summary of the results is presented in Figure 9. Specifically, the plot
shows the cumulative distribution function (CDF) of the log-ratio ρ. As in the
case of the one-step prediction, it is readily apparent that the performance of the
proposed method vastly exceeds that of the Markov process based approach.
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The value of CDF at the crossing of the curve with the ρ = 0 line is 0.82 which
means that our method exhibited superior performance in 82% of the predic-
tions. Even in the case of 18% of the predictions in which the Markov process
based method performed better, the performance differential is not substantial.
This is in sharp contrast with the instances in which the proposed method was
better – in 67% of the cases the conditional probability of the correct history
progression was over 100 greater for our model.
4.3 Assessing model scalability
Our primary goal here is to examine how the predictive performance of the his-
tory vector based model is affected by the choice of the number of salient diag-
nostic codes (Vasiljeva and Arandjelovic´, 2016a). As in (Arandjelovic´, 2015b)
we too assess the quality of a specific prediction by considering the rank of the
ground truth diagnostic code in the probability ordered list of predictions. For-
mally, let dt be the ground truth diagnostic code which follows a particular his-
tory H . Then the rank r of dt is given by the number of diagnostic codes which
the model predicts as following H with at least the probability p(H → dt):
r = | {d : d ∈ D ∧ p(H → d) ≥ p(H → dt)} |. (17)
We used the same granularity of codes the original work described in (Arand-
jelovic´, 2015b).
Furthermore, we adopt the usual ‘leave one out’ evaluation protocol whereby
the performance of the method is tested with each patient’s data in turn and the
model trained using the data of all other patients. To quantify the aggregate
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performance of the model for specific model parameter values (i.e. the number
of salient diagnoses included in the history vector representation) we use two
well known measures. These are the average rank (a special case of the average
normalized rank (Salton and McGill, 1983) when the set of target matches is
exactly equal to 1) and the normalized area under the cumulative match charac-
teristic (CMC) curve. For each possible rank r (r = 1 . . . n, where n is the worst
possible rank, equal to the number of diagnosis types), the CMC takes on the
value equal to the proportion of predictions which predict the correct diagnosis
at worst with the rank r (Bolle et al., 2005). The ideal performance results in the
CMC having the value 1 across all ranks i.e. in each individual case the correct
diagnosis is ranked 1. The area under the curve is normalized so that it is equal
to 1 in this ideal case.
We started by looking at the effect that changing the number of salient di-
agnosis types, i.e. diagnosis codes with the corresponding (1-to-1) elements in
the history vector, has on the area under the CMC curve. Our experimental re-
sults are captured by the plot in Figure 10(a). The plot can be readily seen to
support our hypothesis that predicted a decay in the adopted model’s predic-
tion performance for an increasing number of explicitly modelled diagnoses.
Notwithstanding this unwelcome qualitative observation, the major result is of
a quantitative nature – the rate of the aforementioned decay is very slow indeed.
Like many other natural phenomena the decay exhibits a power-law form with
the associated exponent value which differs from 1 by only 5 parts in 100,000
i.e. it is equal to 1 − 0.5 × 10−5. The practical significance of this finding is
better appreciated by considering the plot in Figure 10(b). This plot shows the
Towards Sophisticated Learning from EHR 27
variation in the area under the CMC curve as a function of the coverage of the
entire diagnosis data corpus by the salient codes. The outstanding performance
of the adopted method is illustrated well by noting, for example, that the di-
mensionality of history vectors can be increased to explicitly model the number
of most frequent diagnosis codes which cover over 91% of the data, with the
predictive performance of the method dropping by a mere 0.5% as compared
to the coverage of only 61%. Even 98% of data coverage results in a change
of only 0.8%. Recall that in the original paper the authors used 30 codes which
accounted for 75% of the diagnoses in the corpus. Our results demonstrate that
this was an overly conservative value.
We next examined the average prediction rank of the correct diagnosis type,
which offers further insight into the performance of the adopted method. As
expected from the previous set of findings, the results summarized by the plots
in Figures 11(a) and 11(b) corroborate the observation that an increase in the
dimensionality of history vectors, a key parameter of the method, worsens per-
formance. In this experiment this worsening is exhibited as an increase in the
average rank (i.e. a greater number of incorrect predictions are made with a
higher probability than the actual ground truth diagnosis type). It is interesting
to note the significance of what appears to be a much more rapid performance
deterioration in terms of this performance measure in comparison with the area
under the CMC curve discussed previously. For example, while the use of 200
vs. 10 most frequent diagnosis codes effects a reduction of only 0.5% in the
area under the CMC curve, the corresponding change in the average rank of the
correct diagnosis type increases fivefold (from approximately 1.5 for 10 salient
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codes, to approximately 7.3 for 200 salient codes). The explanation for this ap-
parent discrepancy is in fact reassuring as it demonstrates that the most dramatic
changes in the predicted rank happen for predictions which are already not very
good i.e. the small number of bad predictions become even worse, rather than
good predictions becoming bad.
Lastly, to examine in additional detail how an increase in the number of ex-
plicitly modelled diagnosis types affects predictions, we looked at prediction
rank histograms for different diagnosis codes and the corresponding changes as
their number was changed. Figures 12(a) and 12(b) contrast the histograms for
20 and 50 salient diagnosis types. It is remarkable to observe that in both cases
the histograms are virtually identical across different codes within the same
model. Rather than being effected by sub-par histograms of the added codes,
the (small, as demonstrated previously) deterioration in predictive performance
as the number of salient diagnosis types is increased, is effected by slightly
worse predictive performance uniformly distributed across different diagnoses.
This is highly preferable in practice as it implies that for a fixed model com-
plexity predictive power remains the same regardless of the patient’s ailment.
Were it otherwise, the predictions would be more difficult to interpret and the
model complexity more challenging to set appropriately as the model’s predic-
tive performance would exhibit dependence on the nature of the health problems
affecting a specific patient.
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4.3.1 Assessing the effects of incorporating explicit clinical knowledge
Firstly we examined how the number of transition merges changes with the
variation in the values of the two free parameters, namely the merging threshold
tm and the relative risk weighting constant Cx in (9) and (10). We applied our
method to the entire EHRs data set though, as noted in the previous section,
in practice it is likely that different parameters would be applied to different
sub-trees of the diagnosis coding hierarchy.
Our findings are summarized by the surface plot shown in Figure 13. While
it is inherently the case that increasing tm cannot reduce the number of merges
made, the characteristics of the corresponding change are insightful to the clin-
ician in that they can be used to guide the choice of the risk weighting con-
stant. Notice, for example, that the number of effected merges increases approx-
imately linearly across the entire range of tm for Cx smaller than approximately
0.5 whereas for Cx greater than 0.5 there is a much more sudden increase.
Next we examined salient diagnoses df (see Section 3.2) associated with
the greatest number of merges. We noticed that the diagnosis of stroke was one
of the particularly represented diagnosis amongst these, across different values
of tm and Cx, so we examined the corresponding merging behaviour in more
detail. Interpreted intuitively, this means that on average the diagnosis of stroke
has the least effect on (from the set of salient diagnoses included in the history
vector) the prognosis of other ailments. The family of curves for different values
of Cx, showing the variation of the number of merges (as the proportion of all
possible transitions pairs which could possibly be merged and associated with
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transitions effected by the diagnosis of stroke) as a function of the merging
threshold tm is shown in Figure 14. It is insightful to observe that much like
in Figure 13, an increase in Cx results in more merges for the same value of
tm. A careful consideration of characteristics such as this one is crucial in the
practical deployment of the proposed method, and the choice of granularity (in
the context of the diagnosis coding hierarchy) at which the method is applied
and its parameters.
5 Summary and future work
In this paper we introduced a novel algorithm that uses machine learning on
EHR collections for the discovery of longitudinal patterns in the diagnoses of
diseases. The two key technical novelties are: (i) a novel learning paradigm
which enables greater learning specificity, and (ii) a method for risk driven iden-
tification of confounding diagnoses. A series of experiments were presented to
demonstrate the effectiveness of the proposed techniques. Novel insights result-
ing from our experimental findings were also discussed and highlighted.
As regards possible future work directions, a number of possibilities were
proposed by the authors of the original history vector based approach that the
present method was partly inspired by. While we agree with most of these in
broad terms, our contributions, experiments, and results suggest what we be-
lieve to be more promising immediate alternatives. In particular while we agree
with the authors of the original method that the presence of a particular episode
of care is a predictive factor not much weaker than the exact number of episodes
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(which would require a prohibitively large amount of training data to learn), we
believe that history vector binarization is an overly harsh step for the reduc-
tion of the learning space. Following the spirit of the method introduced in the
present paper we intend to explore the possibility of automatically detecting
chronic types of episodes of care (such as dialysis, for example) and then using
a binary representation for non-chronic, and a more graded representation for
chronic conditions.
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Fig. 1 Causes of death for the developed world (Western Europe), developing
nations (Subsaharan Africa), and the world average.
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Fig. 2 Frequency (red line) and cumulative frequency of different diagnoses.
The plot illustrates the highly uneven distribution, with the top 30 most frequent
diagnoses accounting for 75% of the entire data corpus.
Towards Sophisticated Learning from EHR 41
Fig. 3 Conceptual illustration of the method proposed by (Arandjelovic´, 2015b)
which superimposes a Markovian model over a space of history vectors used to
represent the medical state of a patient.
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Fig. 4 (a) Patient age is not associated with the total number of admissions of
the patient. (b) Patient age shows low association (r = 0.14, p < 0.001) with
the number of conditions the patient has been diagnosed with.
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Fig. 5 (a) The presence of a particular condition in a patient’s history is a good
predictor of the total number admissions. (b) Average number of admissions for
patients containing a particular diagnosed condition in their history.
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Fig. 6 (a) Repeated diagnosis statistics for the top 30 diagnosed conditions.
(b) Average number of repeated admussions and the probability of a repeated
diagnosis for a particular condition.
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Fig. 7 Cumulative match characteristics (CMCs) for the prediction of the next
diagnosis from a patient’s history.
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Fig. 8 Partial history length vs. next diagnosis prediction rank.
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Fig. 9 Cumulative density function of the ratio of the probabilities of true pa-
tient medical history progression for the diagnoses-level Markov process ap-
proach and the proposed method.
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Fig. 10 The normalized area under the cumulative match characteristic (CMC)
curve.
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Fig. 11 The average prediction rank of the correct diagnosis type.
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(a)
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Fig. 12 Prediction rank histograms across different diagnosis codes using (a)
20 vs. (b) 50 salient codes.
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Fig. 13 Surface plot showing the number of pair-wise merges performed (as
the proportion of all possible transitions pairs which could possibly be merged)
as a function of the adjustable parameters of the proposed method, namely the
merging threshold tm and the relative risk weighting constantCx in (9) and (10).
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Fig. 14 The number of effected merges associated with the diagnosis of stroke
(as df in Section 3.2) as the proportion of all possible transitions pairs which
could possibly be merged and associated with transitions effected by the diag-
nosis of stroke.
